Publicaciones en las que colabora con PATRICIA ESMERALDA CARREIRA DELGADO (33)

2022

  1. Inmune-mediated inflammatory rheumatic diseases in transgender people: A scoping review

    Seminars in Arthritis and Rheumatism, Vol. 52

2019

  1. Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanercept

    PLoS ONE, Vol. 14, Núm. 2

2018

  1. Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis

    PLoS ONE, Vol. 13, Núm. 5

2016

  1. Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis

    Pharmacogenomics Journal, Vol. 16, Núm. 2, pp. 137-140

2015

  1. FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors

    Pharmacogenomics, Vol. 16, Núm. 4, pp. 333-345

  2. Rheumatoid arthritis response to treatment across IgG1 allotype - anti-TNF incompatibility: A case-only study

    Arthritis Research and Therapy, Vol. 17, Núm. 1

2014

  1. Association of FCGR2A with the response to infliximab treatment of patients with rheumatoid arthritis

    Pharmacogenetics and Genomics, Vol. 24, Núm. 5, pp. 238-245

  2. Lack of replication of higher genetic risk load in men than in women with systemic lupus erythematosus

    Arthritis Research and Therapy, Vol. 16, Núm. 3

  3. Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: A genome-wide association study replication and meta-analysis

    Arthritis Research and Therapy, Vol. 16, Núm. 2

2012

  1. Bias in effect size of systemic lupus erythematosus susceptibility loci across Europe: A case-control study

    Arthritis Research and Therapy, Vol. 14, Núm. 2

  2. Further Evidence of Subphenotype Association with Systemic Lupus Erythematosus Susceptibility Loci: A European Cases Only Study

    PLoS ONE, Vol. 7, Núm. 9

2011

  1. Association of systemic lupus erythematosus clinical features with european population genetic substructure

    PLoS ONE, Vol. 6, Núm. 12

2009

  1. Replication of recently identified systemic lupus erythematosus genetic associations: A case-control study

    Arthritis Research and Therapy, Vol. 11, Núm. 3

2007

  1. Opposed independent effects and epistasis in the complex association of IRF5 to SLE

    Genes and Immunity, Vol. 8, Núm. 5, pp. 429-438

  2. Study of DNASE I gene polymorphisms in systemic lupus erythematosus susceptibility [3]

    Annals of the Rheumatic Diseases

2006

  1. Association of a non-synonymous single-nucleotide polymorphism of DNASEI with SLE susceptibility

    Rheumatology, Vol. 45, Núm. 7, pp. 819-823

2005

  1. Polymorphism of the interleukin-1 receptor antagonist gene: A factor in susceptibility to rheumatoid arthritis in a Spanish population

    Arthritis and Rheumatism, Vol. 52, Núm. 10, pp. 3015-3019

2004

  1. Association of PDCD1 with susceptibility to systemic lupus erythematosus: Evidence of population-specific effects

    Arthritis and Rheumatism, Vol. 50, Núm. 8, pp. 2590-2597

2003

  1. The three most common CARD15 mutations associated with Crohn's disease and the chromosome 16 susceptibility locus for systemic lupus erythematosus

    Rheumatology, Vol. 42, Núm. 4, pp. 570-574

1999

  1. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5

    Arthritis and Rheumatism, Vol. 42, Núm. 5, pp. 989-992